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INTRODUCTION
Diabetes mellitus (DM) is a common metabolic disease that caus-
es various impairments of the body systems. The relationship
between diabetes mellitus and hearing function has been studied
for a long time, yet there is currently no adequate consensus on
this topic. Many clinical studies (1-8) have shown a direct correla-
tion between hearing loss and diabetes, but other studies (9-11)
did not identify this association. In addition, several investigators
have reported various patterns of hearing loss in diabetic
patients. One of these patterns is progressive, gradual bilateral
sensorineural hearing loss that especially affects high frequencies
and the elderly. This would be similar to presbycusis, but with
more severe losses than those expected with normal aging (10,
12, 13). Other studies have reported hearing loss of the low and
medium frequencies (6, 14). There are many reasons for the
discrepancy in the results from these clinical studies; one reason
is that it is difficult to perform histological assessment in human
beings. The limited size of the study population and many vari-
ables such as the use of drugs, noise exposure, genetic affections
and other systemic diseases may contribute to the difficulties of
performing human studies.
The effects of diabetes on hearing have been investigated in
animal models by using diabetogenic drugs (alloxan or strepto-
zocin) or genetic modifications. Triana et al. study used a rat line
that was a genetic model of non-insulin-dependent diabetes melli-
tus, and they reported that a significant loss of outer hair cells was
noted in the diabetic obese rats when compared with the control
obese animals (15). However, other authors that used the same
animal model reported that diabetes alone did not cause signifi-
cant basement membrane thickening (16). Ob/ob mice (OM) are
hyperphagic, obese, hyperinsulinemic and hyperglycemic, and
they have been used as a model for type 2 diabetes and obesity
(17). The purpose of this study was to assess the pattern of hear-
ing loss according to aging in OM.
Objectives. There have been many studies on the relationship between diabetes mellitus and presbycusis. Microangiopathy
and neuropathy that’s caused by chronic hyperglycemia may lead to damage to the inner ear. Several clinical stud-
ies on humans and animal studies have been performed to investigate the association between diabetes and hear-
ing loss, however, this relationship is still a matter of debate. We investigated the association of diabetes and sen-
sorineural hearing loss in an animal model of type-2 diabetes and obesity (the ob/ob mouse [OM]).
Methods. The auditory brainstem response (ABR) thresholds were obtained in the OM and the wild type mice (C57BL/
6J mice) up to 25 weeks after birth. After the animals were sacrificed, their cochleae were retrieved and then sub-
jected to histopathologic observations.
Results. The OM exhibited significantly elevated ABR thresholds at 21 weeks of age, yet the C57BL/6J mice exhibited no
significant change until 25 weeks of age. On the histological findings, outer hair cell degeneration and loss of spiral
ganglion cells were observed in the middle and basal turns of the OM. On the contrary, no degenerative change was
observed until 25 weeks of age in the C57BL/6J mice.
Conclusion. This study suggests that chronic hyperglycemia and obesity may lead to early sensorineural hearing loss.
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MATERIALS AND METHODS
Experimental animals
Female OM and female wild-type C57BL/6J mice, all 3 weeks
old, were purchased from the Jackson Laboratory (Bar Harbor,
ME, USA). The mice were kept in specific pathogen-free condi-
tions and in accordance with Samsung Biomedical Research
Institute’s Principles of Laboratory Animal Care and Guide for
the Use of Laboratory Animals. The mice were given free access
to food and water and they were placed in a humid environment
at a constant temperature with a 12-hr light/dark cycle.
Body weight and the glucose and lipid levels 
The body weight and the blood glucose and plasma levels of total
cholesterol, triglyceride, LDL cholesterol and HDL cholesterol
were determined for every mouse at 5, 9, 13, 17, 21, and 25 weeks
of age. Food was not restricted for the blood glucose and lipid
analyses. Blood samples were obtained by cardiac puncture and
the blood was placed into heparin-coated 1.5-mL capillary tubes,
about 0.5 to 1.0 mL from each mouse. The plasma was retrieved
after immediate centrifugation for 15 min at 12,000 g at 4℃ and
the samples were stored at -80℃ until they were assayed. The
plasma levels of total cholesterol, triglyceride, LDL cholesterol,
HDL cholesterol and blood glucose were measured by using a
clinic chemical system.
Auditory brainstem response (ABR) Recordings
The auditory thresholds were taken for every mouse at the age
of 5, 9, 13, 17, 21 and 25 weeks. The auditory thresholds were
measured in response to rarefaction clicks (0.1 ms) and tone bursts
of 8, 16, and 32 kHz (1 ms rise/fall time, 2 ms plateau and a 11/sec
presentation rate) that were generated via an ABR workstation
(Tucker Davis, FL, USA), and these were presented via an insert
ear phone (Etymotic ER-2, Elk Grove Village, IL, USA). The ani-
mals’ ears were checked with an operating microscope to ensure
that the middle ear was free of infections and fluid. The animals
were anesthetized with ketamine (40 mg/kg) and xylazine (5 mg/
kg), and then they were placed in an electrically and acoustical-
ly shielded sound attenuation booth. Needle electrodes were
placed subdermally at the vertex (active electrode) of the skull,
in the postauricular region (reference electrode) and on the back
(ground electrode). The potentials were filtered (0.3-3 kHz), dig-
itized and averaged with using Tucker-Davis ABR workstation
software. The ABR waveforms were averaged (500 sweeps) over
a 10-ms time window. Threshold was defined as the lowest inten-
sity for the last visibly repeatable response. The presentation lev-
els of the stimuli varied in 10-dB steps, and they varied in 5-dB
steps near the threshold.
Fig. 1. Body weight and the blood glucose and lipid levels in the ob/ob mice (OM) and the age-matched C57BL/6J mice (mean±SD). The body
weights of the OM were significantly higher than those of the C57BL/6J mice from 5 weeks of age (A). The blood glucose, total cholesterol, LDL
cholesterol and HDL cholesterol levels of the OM were higher than those of the C57BL/6J mice over most of the ages (B, C, E, and F). No signifi-
cant difference was noted in the triglyceride levels among the two groups (D). *P<0.05, n=12 (OM), 11 (C57BL/6J mice).
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Histology
Two or three animals were sacrificed at the age of 5, 9, 13, 17,
21, and 25 weeks, respectively. The animals were deeply anes-
thetized with ketamine (40 mg/kg) and xylazine (5 mg/kg) and
then they were fixed by cardiac perfusion (4% paraformaldehyde
in phosphate buffer). After decalcification in EDTA for 2 weeks
and embedding in paraffin, 5-μ m sections were cut in a paramodi-
olar plane. Every fifth section was mounted on a glass slide and
stained with H&E. For scanning electron microscopy (SEM), the
anesthetized animals were sacrificed and the cochleae were re-
moved and the perilymphatic space was perfused with 2.5% glu-
taraldehyde in 0.1 M cacodylate (CaC) buffer. The following day,
the cochleae were rinsed with Cac buffer and then perfused with
1.5% osmium tetroxide. The cochleae were then rinsed with Cac
buffer. Under the dissecting microscope, the bony capsule and
lateral wall of cochlea were removed to expose the organ of Corti.
The cochleae were then dehydrated in increasing concentrations
of ethanol, from 70 to 100%, and they were critical point dried.
Each specimen was mounted on a SEM stub and sputter coated
with 10 nm gold/palladium alloy. The cochleae were viewed and
photographed with a Hitachi S-500 scanning electron microscope.
Quantitative analysis was not performed for the histology.
RESULTS
Body weight and the glucose and lipid levels
The body weights were remarkably higher for the ob/ob mice
after 5 weeks as compared with the C57BL/6J mice. The blood
glucose, total cholesterol, LDL and HDL cholesterol, except the
TG, were significantly higher in the OM, as compared with the
C57BL/6J mice, for all the ages of mice (Fig. 1).
ABR thresholds
For the click sounds, a significant difference of thresholds between
the two groups was first found at 9 weeks of age. At higher fre-
quencies, a threshold difference was found at earlier ages and the
difference became greater according to aging (Fig. 2).
Histology
Fig. 3 showed the light microscopic findings of the cochlea. In
the C57BL/6J mouse, the outer hair cells (OHCs) and inner hair
cells (IHCs) looked intact in the organ of Corti with no obvious
neuron loss in the spiral ganglion. However, after 21-weeks of
age, the organ of Corti in the cochlear base and middle was signif-
icantly degenerated in the OM. On the scanning electron micro-
scopic findings, the IHCs and OHCs looked intact in the C57Bl/
Fig. 2. Comparison of the ABR thresholds in the ob/ob mice (OM) and age-matched C57BL/6J mice. For the click sounds, more hearing loss
was found from 9 weeks of age in the OM and the differences were greater according to increasing age (A). For the 8 kHz tone pip, significant
differences in thresholds were found from 21 weeks of age (B). At 16 and 32 kHz, the differences between the two groups were significant from
13 weeks of age (C and D). *P<0.05, n=12 (OM), 11 (C57BL/6J mice).
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6J mice of all ages. On the contrary, degeneration of the OHCs
was observed in the 25-week-old OM (Fig. 4).
DISCUSSION
DM is one of the most common metabolic disorders, and its preva-
lence increases with age. Insulin resistance or type-2 (DM) is often
associated with the most commonly occurring metabolic and physi-
ologic problems, including elevated blood pressure, cardiovascu-
lar disease, dyslipidemia (high triglyceride levels and low levels
of high-density lipoproteins) and high cholesterol levels. The asso-
ciation between hearing loss and DM has been debated since it
was first reported by Jordao in 1857 (18). Kakarlapudi et al. (5)
reported that sensorineural hearing loss was more common in
diabetic patients than in their age-matched controls. Vaughan et
al. (19) noted that diabetic patients 60 yr old or younger may show
early high-frequency hearing loss similar to early presbycusis, but
after the age of 60, the difference in hearing loss between diabet-
ic and nondiabetic patients was reduced. Frisna et al. (4), in their
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Fig. 3. Comparison of the light microscopic findings of the organ of Corti in the C57BL/6J mice and the ob/ob mice (OM) (representative sec-
tions). All the sections of the C57BL/6J mice showed a normal organ of Corti and spiral ganglion cells (A: basal turn at 13 weeks of age, B:
basal turn at 21 weeks, C: middle turn at 25 weeks and D: basal turn at 25 weeks, respectively). In the OM at 25 weeks of age, the organ of
Corti was degenerated (arrow head) and there was significant loss of spiral ganglion cells (arrows) (E: basal turn at 13 weeks of age, F: basal
turn at 21 weeks, G: middle turn at 25 weeks and H: basal turn at 25 weeks, respectively). H&E stain, scale bars=100 μ m.
A B C D
E F G H
Fig. 4. Representative SEM photomicrographs of the organ of Corti from the C57BL/6J mice and the ob/ob mice (OM). The organ of Corti mor-
phology was very well preserved in the C57BL/6J mice of all ages (A-D: mid-basal turns at 5, 9, 21 and 25 weeks of age, respectively). In con-
trast, some of the outer hair cells were degenerated at 21 and 25 weeks of age, and degeneration of the inner hair cells was found at 25 weeks
of age in the OM (E, F: mid-basal turns at 5, 9, 21, and 25 weeks of age, respectively). Scale bars=10 μ m.study investigating hearing loss in aged type-2 diabetics and age-
matched controls, found a significant difference between both
study groups in the inner ear and also a central hearing loss. In-
terestingly, in that study, the lower frequencies tended to be more
affected than the higher frequencies. However, other authors did
not find the same association (9-11). There are also controversial
reports about the pattern of the hearing loss found in diabetic
patients. A small number of studies have assessed human tem-
poral bones from patients with DM. Fukushima et al. demonstrat-
ed that cochlear microangiopathy and degeneration of the stria
vascularis and cochlear outer hair cells were found in patients with
type 2 DM. They also reported a significantly greater loss of outer
hair cells in the basal turns in diabetics, as compared with the con-
trol group (20). Wackym and Linthicum (21) reported that dia-
betic sensorineural hearing loss was the result of microangiopath-
ic involvement of the endolymphatic sac and/or basilar membrane
vessels. However, they noted no significant differences in the mean
estimated percentage of hair cells and stria vascularis cells between
the diabetic and nondiabetic patients. 
The effects of diabetes on hearing have been investigated in
animal models. Smith et al. demonstrated basement-membrane
thickening that was consistent with diabetic microangiopathy in
the inner ear of streptozocin-induced diabetic rats (22). Raynor
et al. (23) observed that the loss of the outer hair cells was greater
in the rats with diabetes induced by streptozocin and that were
simultaneously exposed to noise. However, drug-induced diabetic
animals do not reflect the real physiological mechanism of dia-
betes in human beings. Thus, genetically modified animals such
as Sabra line rats have been more frequently used in research.
Nageris et al. used rats of the Sabra line and they demonstrated
no statistical difference in the inner and outer hair cells or in the
stria vascularis between the genetically induced diabetic rats and
the control rats. 
Diabetes and obesity are complex genetic diseases that are
caused by a combination of a genetic predisposition and environ-
mental factors. The genetic contribution can be either monogenic
or polygenic, with polygenic inheritance being the predominant
mode of inheritance for human type 2 diabetes and obesity. Al-
though it is rare, single mutations causing monogenic obesity have
been identified. Notable among these are mutations of the lep-
tin gene, leading to a complete deficiency of the adipocyte-pro-
duced protein hormone leptin. The Lep
obmutation arose sponta-
neously in C57BL/6J mice (commonly referred to as OM) (24).
The OM is grossly overweight and hyperphagic, particularly at
young ages, and it develops severe insulin resistance. These mice
have been have been used as a model for obesity and type-2 dia-
betes, and they also have dysfunctions, in association with their
leptin deficiency, in the immune system and the cardiovascular
system, including problems with angiogenesis, supportive tissue
repairs, malignancies and reproduction (17). In our study, we com-
pared the ABR thresholds of the OM with age-matched C57BL/
6J mice, according to aging. The OM demonstrated early sen-
sorineural hearing loss in comparison with the C57BL/6J mice,
and this observation is similar with that from an earlier human
study (12). Although quantitative analysis was not performed
for the histology, we clearly observed degeneration of the organ
of Corti and loss of the spiral ganglion cells in the cochlear basal
turn of the OM in comparison with the C57BL/6J mice.
The sequelae of chronic hyperglycemia in diabetes of all phe-
notypes are divided into the microvascular and macrovascular
complications. Microvascular disease causes blindness, renal fail-
ure and neuropathy, and diabetes-accelerated macrovascular dis-
ease causes an excessive risk for myocardial infarction, stroke and
lower limb amputation. The link between chronic hyperglycemia
and vascular damage has been established by four independent
biochemical abnormalities: increased polyol pathway flux, increased
formation of advanced glycation end products, activation of pro-
tein kinase C and increased hexosamine pathway flux. In the
cochlea, Smith et al. demonstrated basement-membrane thick-
ening in the cochlea, which is consistent with diabetic microan-
giopathy in the inner ear of IDDM rats (22). Also in a study on
human temporal bone, the walls of the vessels of the basilar mem-
brane and stria vascularis in diabetics were significantly thicker
than those of the controls (20). Although microangiopathy is an
important factor in the cochlear disease of diabetic patients, other
precipitating factors such as oxidative stress and apoptosis due to
a hyperglycemic state, noise and hypertension can work syner-
gistically to cause the observed pathologic changes in the stria
vascularis and the outer hair cells (20). 
We observed early loss of the spiral ganglion cells in the OM.
Raynor et al. (23) and Ishikawa et al. (25) previously reported
the loss of spiral ganglion cells in an animal model of diabetes.
However, Fukushima et al. noted no significant difference in the
number of spiral ganglion cells or inner hair cells between the
diabetics and controls in a human temporal bone study (20). Al-
though OM have been used as an animal model for diabetes, some
aspects of this animal are different from human type-2 diabetes.
Early obesity in OM can be reversed almost completely, even in
adult animals, by exogenous leptin or transfection with the lep-
tin gene. There are also cases with leptin deficiency in obese hu-
mans, but this is uncommon and early obesity in type-2 diabetes
patients is not usual (17). In addition, uncontrolled severe hyper-
glycemia as was seen in the OM in this study is not common in
human patients. Severe obesity and dyslipidemia also might addi-
tively affect cochlear degeneration in the OM, as compared to
type 2 diabetic humans. The earlier development of diabetes and
obesity in OM may influence the normal development of audi-
tory function, as compared to human type 2 diabetes. However,
considering that the P18-20 mouse usually shows adult-like mature
ABR waveforms (26), and that the OM showed later elevation
of the ABR thresholds in our study, acquired hyperglycemia and
obesity appeared to contribute much more to cochlear degener-
ation than do any genetic or developmental alterations. Obesity
may also lead to a decrease in Na and K-ATPase in the nerves
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of patients with diabetic angiopathy. The Na and K-ATPase lev-
els of hyperglycemic-hyperinsulinemic OM were recently report-
ed to be reduced in the liver and kidney, as compared with the
lean control animals (27). So, the loss of spiral ganglion cells in
the OM might be caused by hyperglycemia and severe obesity.
CONCLUSIONS
We demonstrated that OM, an animal model for type-2 diabetes
and obesity, showed earlier sensorineural hearing loss as com-
pared with the C57BL/6J mouse. We also observed earlier degen-
eration of the organ of Corti and the spiral ganglion cells on the
histology. This study suggests that severe hyperglycemia and obe-
sity may lead to early cochlear degeneration.
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